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in the Canine
Lisa E. Tuttle, B.S. *
Ronald L. Grier, DVM, PhD * *
Introduction
Neoplasms of the nasal and paranasal
sinuses make up approximately 1% of canine
tumors. 1-5 These tumor~ are malignant in
80 % of the cases, and 60 - 75 % are carcino-
mas. 2 ,6 According to most authors, adenocar-
cinomas are the most cornrnon nasal tumor,
followed by squamous cell carcinoma. Large
and n1edium sized dogs in the 8-10 year age
group are most commonly affected. Some
authors find the dolicocephalic breeds to be
the most prone to develop adenocarcinoma,5,7
while others find the number of cases higher
in the n1esocephalic breeds. 3,4 Some reports
show a higher incidence of nasal adenocarci-
noma in male dogs,5,7,8 but when correction is
made for sex distribution of th~ number of
cases seen, there is no difference in nasal tu-
mor incidence between males and females. 2 ,8,6
There is no known etiological agent for nasal
adenocarcinoma, and there is no difference
between urban and rural dogs with respect to
nasal and sinus neoplasia. 5,9
Nasal adenocarcinon1as are primary tu-
mors of the respiratory epithelium covering
the respiratory portion (maxilloturbinates,
ethmoturbinates, nasoturbinates, and nasal
septum) of the nose10 which kill by local inva-
sion; metastasis is rare. Unfortunatley, early
diagnosis and treatment is difficult to accom-
plish because clinical signs appear only after
the tumor is fairly well advanced. Treatment
of this type of tumor has not been very
successful, and the mortality rate associated
with nasal and sinus adenocarcinoma is quite
high.1.7 With conventional treatments, mean
survival times are reported at 4- 6
months. 4 ,6,7,8
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Theories of Carcinogenesis
The basic cellular events in neoplastic
transformation are similar whether transfor-
mation is brought about by chemical, radia-
tion, physical, or viral agents. Therefore, al-
though the etiology of nasal carcinoma is
unknown, a general discussion of carcino-
genesis is still pertinent. All of these cellular
events change nuclear DNA in such a way
that it can be transmitted from a cell to its
daughter cells.
Carcinogenesis appears to be a multi-staged
process. The transformation or "initiation"
stage is followed by a "promoting" event which
allows the potentially neoplastic cell to prolif-
erate. Promoting factors include local tissue
injury or hormonal influences which stimulate
cells to divide. They may also include im-
paired immunological function in which
transformed cells, normally kept in check by
the immune response, may proliferate un-
checked. For example, radiation, through its
ability to cause local tissue damage as well as
immune suppression, may serve as both in-
itiator and promoter of neoplastic transforma-
tion. 10
There are many reports of chemically-in-
duced tumor formation in animals. The car-
cinogenicity of nitrosamines is due to tissue
conversion to carcinogenic metabolites. The
nasal mucosa is a site with marked nitros-
amine metabolizing capacity.lO In addition to
a local carcinogenic effect, parenterally ad-
ministered nitrosamines are transported in
the bloodsteam to the nasal cavity.11 DMCC,
a carbamic acid derivative known to have car-
cinogenic properties, is used as an intermedi-
ate in the production of certain carbamate
pesticides. 10 HMPA (hexamethyl-phos-
phoramide) is used in the production of
several types of plastics, and has been shown
to selectively induce nasal tumors. ll
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Clinical Description
Early clinical signs of nasal and sinus ade-
nocarcinoma are nonspecific, and most cases
a veterinarian sees are already well advanced.
No pathognomonic clinical pathological,
physical, or radiographic signs appear until a
substantial part of the nasal cavity is involved.
An average of 2-6 months elapse between the
onset of clinical signs and the definitive
diagnosis. 3 ,6
Common signs of an acute nasal tumor are
unilateral nasal or ocular serous discharge,
turning mucopurulent due to secondary bac-
terial invasion, and then proceding to hemor-
rhage and sneezing. 1 ,2,5,6,11 As the lesion pro-
gresses, the nasolacrimal duct may become
obstructed2,6 resulting in a mucoid ocular dis-
charge. If the tumor erodes through the corti-
cal bone of the maxilla or nasal bones, facial
swelling (with or without ulceration) and dis-
tortion may result. 2, 7 Ocular signs such as ex-
ophthalmos, scleral injection, and conjunc-
tivitis result when the tumor invades the orbit
in advanced cases.1,2,6 Often, the nasal dis-
charge has a fetid odor from necrotic tissue. 9
The animal may paw at its nose, presumably
from the pain associated with a rapidly grow-
ing tumor in a small, enclosed area. 7 The tu-
mor may invade the cranial cavity, in which
case neurological signs such as violent
seizuring can occur. 7,9Differential diagnoses
include a chronic rhinitis secondary to infec-
tion or trauma, foreign body lodged in the
nasal cavity, fungal disease, tooth root
abscess, and in certain geographical areas,
Linguatula serrata or Pneumonyssus caninum.
Diagnosis
Physical examination of the nasal passages
is best done while the animal is under general
anesthesia. An otoscope works well to evalu-
ate the rostral third of the nasal cavity. In-
tranasal neoplasia rarely involves this part of
the nasal cavity even in advanced cases, but
anterior rhinoscopy can help to eliminate na-
sal foreign body as the cause of the observed
clinical signs. Rhinoscopy of the posterior na-
sal cavity can be accomplished using a dental
mirror and a .good light source, after the soft
palate is retracted rostrally. This examination
aids in ruling out abnormalities such as soft
palate polyps and nasopharyngeal tumors in
the caudal nasal cavity. 1
Nasal washings with saline allow one to get
a sample for cytological examination. The
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dog is put in lateral recumbency with the af-
fected side down. An endotracheal tube with
an inflated cuff is used to prevent excess fluid
from reaching the lower airways. A flexible
tube is attached to a 35cc syringe, and 5-10cc
of saline is flushed through the nares, or from
behind the nasopharynx, using alternating
positive and negative pressure. This proce-
dure may have to be repeated several times to
get enough cells for cytological evaluation. 8
Some workers5,7 have obtained false negative
results with this procedure, and diagnosed
non-malignant inflammatory changes only to
have later biopsy results indicate malignant
adenocarcinoma. This is not surprising since
most tumors have reactive tissue in their ma-
trix, especially in the peripheral areas of the
tumor. 7,9 If neoplastic cells are seen, a positive
diagnosis can be made.
Bacterial, mycotic, and yeast cultures
should always be done, keeping in mind that
bacteria isolated from the nasal cavity may be
part of the normal flora (especially if a mixed
culture is obtained) or may be secondary to
the presence of a foreign body or tumor. Un-
der these circumstances, antibiotics will not
cure the secondary rhinitis, although a tem-
porary response may be seen. 1,2 Positive bac-
terial cultures are obtained in over 60 % of the
nasal discharges cultured, with a variety of
organisms recovered (i. e. coliforms, strepto-
coccus, staphylococcus).2 Of the fungal dis-
eases which affect the nasal cavity and sinuses,
aspergillosis is most common, with blastomy-
cosis, cryptococcosis, and nasal penicilliosis
occurring less frequently. 2
The lesion can be biopsied either through a
surgical approach through the nasal bones
prior to curettage of the sinuses and/or nasal
cavity, or by introducing a large-gauge poly-
propylene urinary catheter into the nose. The
catheter is cut at a 45° angle to form a sharp
cutting edge. The catheter is advanced into
the site of the lesion via an otoscope specu-
1um' and suction is applied using a 12cc
syringe. Plugs of tissue can be obtained in this
manner. The cell type which is the origin of
the nasal tumor is impossible to determine, as
all of the mucosa of the nasal cavity and
sinuses consists of pseudostratified columnar
epithelium, and both mucous and serous
glands are found beneath the basement mem-
brane. Malignant epithelial neoplasms ori-
ginating in the nasal cavity could conceivably
have originated from any of these normal
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structures. 6
Perhaps the most reliable way of diagnosing
an advanced nasal neoplasm is by radio-
graphy. The animal should be under general
anesthesia, and in addition to the routine ven-
trodorsal and lateral projections of the skull,
frontal sinus, open-mouth and intraoral non-
screen films should be taken. 1,2,5 A consistent
sign of an early nasal epithelial cell tumor is a
unilateral increased soft tissue density of the
turbinates which results in a loss of the fine
trabecular pattern of the normal turbi-
nates. 1,2,5,6,7 This homogeneous density is the
result of cells, debris, and fluid silhouetting
with the turbinates. At this point, the appear-
ance of the early epithelial tumor and a non-
destructive inflammatory response can be
similar, but as the tumor progresses, the den-
sity surrounding the turbinates becomes more
heterogeneous from advancing turbinate de-
struction.2 Nasal septum and vomer bone ero-
sion can occur from a malignant neo-
plasm.2,5,6,7 Destruction of overlying cortical
bone is a feature of neoplastic processes. 2,6
Nasal mycosis typically results in a more lu-
cent than normal nasal cavity as opposed to
the increased density seen with adenocarci-
noma. Radiographic changes suggesting a
chronic inflammatory process (bacterial or al-
lergic) include bilateral increased tissue densi-
ties, exaggerated or coarse trabecular turbi-
nate changes, minimal alterations in
overlying bone and complete or partial resolu-
tion of the lesion on serial radiographs. 2
Therapy
The total physical status of the animal must
be considered before any type of therapy is
undertaken. All forms of cancer therapy are
toxic to some degree and it is the veterinari-
an's responsibility to ascertain if the patient
can survive therapy. A GBG and blood
chemistries should always be run before a
treatment regime is started. The frequency of
administration may also be a factor to be con-
sidered if the treatment, e. g. radiotherapy, is
located a great distance from client's home.
The client should also be forewarned that fol-
low-up visits will be necessary to monitor
therapeutic results. .
Surgery is perhaps the first therapy consId-
ered when nasal or sinus adenocarcinoma is
strongly suspected or diagnosed. However, its
value is in allowing the surgeon to "debulk"
the tumor and in providing biopsy specimens.
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Surgery as the sole therapy for a nasal tumor
offers no benefit for long-term sur-
vival. 5,7,8,12,13,2 The procedure consists of re-
moving a dorsal flap of bone from the nasal
and maxillary bones which mayor may not be
replaced.1,2,7,8,9,14 If the excised bone is not
replaced it is imperative that the periosteum
be preserved to facilitate obtaining an airtight
closure. Once the cavity or sinus is exposed,
radical excision and curettage of the neoplasm
is attempted. The nasal turbinates and sep-
tum are removed when necessary. 8, 12
Gryosurgery is performed after routine sur-
gery and curettage of the nasal cavity.1,8 Liq-
uid nitrogen can be sprayed or poured on the
area to be frozen, but it is probably better to
avoid the latter method as the amount of
freezing is more difficult to control. Thermo-
couples ,are placed outside the maxillary bones
and below the hard palate to estimate the
depth of freezing. Using a commercially avail-
able cryosurgery unit, the maxillary bones,
bony orbit, cribriform plate, and frontal
sinuses can be frozen. The hard palate should
be frozen with caution, as the mucosal cov-
ering of the roof of the mouth can be dam-
aged. The theory behind cryosurgery is that
rapid freezing ( - 20 o G) and slow thawing de-
stroy viable tumor cells that are still left after
curettage. The frozen bone dies but remains
in place as an autogenous bone graft, allowing
revascularization and new bone growth. 8, 12
Hyperthermia is an alternate method of
killing residual tumor cells after the nasal cav-
ity and/or sinuses are curetted, or in conjunc-
tion with radiotherapy. Advocates of hy-
perthermia state that 1) heat suppresses the
ability to repair radiation damage; 2) heat
enhances the expression of lethal radiation
damage; 3) tumor cells may be more heat-
sensitive than normal cells; and 4) hypoxic
cells are more heat-sensitive than aerobic
cells. 15 High frequency current (500 KHz)
with direct or capacitative coupling is applied
to the tumor. Intratumor temperatures are
monitored using 26ga needle thermistor
probes. 14
Radiotherapy is one of the more commonly
used therapies as an adjunct to surgery,3.4,6,7,8
cryosurgery,4 or hyperthermia. 14 Although
many believe that radiotherapy coupled with
surgery offers the best way to manage nasal
tumors2 ,4,6,8 and may prolong the lifespan of
the dog 5-14 n1.onths longer than surgery
alone,15 a drawback is that the equipment re-
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quired is usually available only at universities.
Also, treatments are expensive and often done
on a Monday/Wednesday/Friday schedule for
a period of up to 3 weeks, necessitating fre-
quent trips by the client to the treatment facil-
ity.4,6,8 Radiation is delivered either by using
orthovoltage X-rays, or by using Cobalt or
Cesium to deliver gamma radiation.
Immunotherapy or immunopotentiation is
an attempt to enhance the body's own im-
mune response to disease. It can be used
alone or as an adjunct to other therapy.8 One
treatment is adjuvant therapy using levami-
sole, BCG (Bacillus Calmette-Guerin), or
mixed bacterial vaccine (MBV). 8,15 Adminis-
tered parenterally or intralesionally, this en-
tails fairly long-term treatment, and not all
workers are convinced of its efficacy. 2,15 Major
side effects are fever, chills, nausea, and
vomiting. 15
Tumor-specific vaccines have been used
against some carcinomas. 15 Tumor cells are
taken from the patient's tumor and modified
by various techniques in order to kill the cells
but hopefully maintain their antigenicity.
However, it is unlikely that tumor vaccines
will become commonplace in veterinary medi-
cine due to difficulty in preparing the vaccine.
Chemotherapy is another method of
managing nasal adenocarcinoma in the dog.
There are over 20 anti-cancer drugs commer-
cially available,15 all of which work at a spe-
cific stage of cell division or interfere with spe-
cific cellular reactions to slow down or stop
tumor cell proliferation. Drug dosages are fre-
quently expressed in mg/M2 of body surface
area, as this correlates well with such physio-
logical parameters as blood volume and urea
clearance. Conversion tables are available for
converting mg/kg dosages into mg/M2 do-
sages, as well as for converting kg of body
weight into M 2 of surface area. 5,15
Most chemotherapeutic drugs are toxic to
all dividing cells, and there can be a fine line
between therapeutic and toxic doses. There-
fore, it is essential that all animals undergoing
chemotherapy be closely monitored for toxic
side effects, because most patients with neo-
plasia are older animals. Monitoring should
consist of physical examinations, CBCs and
serum chemistries, and renal function tests
every 7-1 0 days.8,15
Drugs used clinically in treating adenocar-
cinomas include triethylene-thiophos-
phoramide (Thio-TEPA®), fluorouracil, ac-
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tinomycin D, doxorubicin (Adriamycin®),
bleomycin, and L-phenyulalanine mus-
tard. 4,15 No one drug has shown to be very
efficacious in treating nasal tumors. A pilot
study for the efficacy of thioproline was re-
cently conducted at ISU. 16 Although it was
deemed doubtful that thioproline has signifi-
cant cytostatic activity, it decreases epistaxis
(which often results in the decision to eu-
thanize the animal) by interfering with tumor
vascularization. No toxicosis from drug ad-
ministration was found, but pain and absces-
sation at injection sites were frequent compli-
cations.
Conclusion
Although the overall incidence of nasal ade-
nocarcinoma in the canine population is not
high, it is a highly malignant tumor in which
early diagnosis and treatment is necessary.
Nasal tumors should always be considered in
mid-to large-breed dogs with a history of in-
sidious onset of dyspnea, nasal discharge (es-
pecially epistaxis), and sneezing.
At the present time, the best means for
managing canine nasal tumors appears to be a
con1bination of surgery and radiotherapy.
Owners must be made aware that treatment
of advanced nasal carcinoma is only palliative
and helps to relieve the symptoms. There is
no cure for nasal adenocarcinoma, and most
patients die or are euthanized within 12
months of diagnosis.
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